The Role of Medical Affairs in Market Access
Annemarie Clegg Chief Medical Officer at OPEN Health
As complex treatments are developed for ever-more-targeted patient populations and second- and third-generation therapies challenge first-in-class medications, questions of value are increasingly driving patient access. And rather than Market Access teams working in a silo, Medical Affairs is joining the value conversation. Here MAPS speaks with Annemarie Clegg, Chief Medical Officer, OPEN Health, about the evolving role of Medical Affairs in providing context for payers, regulators and policy makers whose decisions can dramatically affect which patients can access industry innovations, and thus influence the impact of these innovations on patient benefit.